Location : Nantes, France

http://www.xenothera.com/

Xenothera

  Biotech, Welness Healthcare  

XENOTHERA’s platform for creating of hyperimmune polyclonal sera is based on the following proprietary processes: Define the proper animal and its genetic background for engineering Choose and optimize the immunogen Turn the animal’s immune response for an optimized therapeutic efficiency Purify the antibodies Lead a translational development program Product and commercialize

READ MORE

Funds raised
19/05/2014
2 000 000 €
06/06/2016
2 000 000 €
18/06/2018
2 000 000 €
08/03/2019
10 000 000 €
Startups in your ecosystem

Access all data in the Startup Pool report

With an Estimeo account, you can access the full Startup Pool report of Xenothera.

Register